Terms: = Pancreatic cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
6 results:
1. Role of Immune Microenvironment in pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
De Simoni O; Dal Santo L; Scarpa M; Munari G; Spolverato YC; Scapinello A; Lonardi S; Soldà C; Bergamo F; Fantin A; Bardini R; Pilati P; Fassan M; Gruppo M
Curr Oncol; 2023 Jun; 30(6):5515-5528. PubMed ID: 37366900
[TBL] [Abstract] [Full Text] [Related]
2. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional pancreatic Neuroendocrine Tumor.
Zhang WH; Wang WQ; Gao HL; Xu SS; Li S; Li TJ; Han X; Xu HX; Li H; Jiang W; Ye LY; Lin X; Wu CT; Yu XJ; Liu L
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32285127
[TBL] [Abstract] [Full Text] [Related]
4. KAI1, a putative marker for metastatic potential in human breast cancer.
Yang X; Welch DR; Phillips KK; Weissman BE; Wei LL
Cancer Lett; 1997 Nov; 119(2):149-55. PubMed ID: 9570365
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium.
Saiki S; Kinouchi T; Kuroda M; Uenaka A; Nakayama E; Kotake T
Jpn J Cancer Res; 1994 Jul; 85(7):756-61. PubMed ID: 8071117
[TBL] [Abstract] [Full Text] [Related]
6. Treatment and outcome of right colon cancers adherent to adjacent organs or the abdominal wall.
Landercasper J; Stolee RT; Steenlage E; Strutt PJ; Cogbill TH
Arch Surg; 1992 Jul; 127(7):841-5; discussion 845-6. PubMed ID: 1388015
[TBL] [Abstract] [Full Text] [Related]
